We are live on ! Find out more
ICU icon

SeaStar Medical
ICU

33 hedge funds and large institutions have $72.7M invested in SeaStar Medical in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 1

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

74% more funds holding

Funds holding: 19 → 33 (+14)

46% more capital invested

Capital invested by funds: $49.6M → $72.7M (+$23.1M)

0.09% more ownership

Funds ownership: 0.2% → 0.28% (+0.09%)

Holders
33
Holders Change
+14
Holders Change %
+73.68%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
+$7.77M
2
PC
Periscope Capital
Ontario, Canada
+$2.97M
3
LP
LMR Partners
United Kingdom
+$1.73M
4
SCM
Saba Capital Management
New York
+$1.49M
5
WRBC
W.R. Berkley Corp
Connecticut
+$1.08M

Top Sellers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
-$1.9M
2
BCM
Basso Capital Management
Connecticut
-$242K
Name Holding Trade Value Shares
Change 		Change in
Stake
KIM
1
Karpus Investment Management
New York
$14M +$7.77M +3,142 +125%
SCM
2
Saba Capital Management
New York
$7.59M +$1.49M +604 +25%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$7.42M – – –
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$3.96M – – –
CH
5
CVI Holdings
Delaware
$3.96M – – –
WRBC
6
W.R. Berkley Corp
Connecticut
$3.83M +$1.08M +437 +39%
BFM
7
Boothbay Fund Management
New York
$3.59M – – –
ASM
8
ATW SPAC Management
New York
$3.47M +$3.46M +1,400 New
HSBC Holdings
9
HSBC Holdings
United Kingdom
$3.05M -$1.9M -767 -38%
MP
10
Mangrove Partners
Connecticut
$2.97M – – –
PC
11
Periscope Capital
Ontario, Canada
$2.97M +$2.97M +1,200 New
RCM
12
Radcliffe Capital Management
Pennsylvania
$2.48M – – –
MSU
13
Mizuho Securities USA
New York
$2.16M +$190K +77 +10%
Goldman Sachs
14
Goldman Sachs
New York
$2.1M – – –
LP
15
LMR Partners
United Kingdom
$1.73M +$1.73M +700 New
Millennium Management
16
Millennium Management
New York
$907K +$905K +366 New
WAM
17
Wolverine Asset Management
Illinois
$872K +$863K +349 +11,633%
Citadel Advisors
18
Citadel Advisors
Florida
$638K +$109K +44 +21%
GCIA
19
Gabelli & Co Investment Advisers
New York
$610K +$608K +246 New
GF
20
Gabelli Funds
New York
$605K +$604K +244 New
PNC Financial Services Group
21
PNC Financial Services Group
Pennsylvania
$557K +$557K +225 New
AA
22
AQR Arbitrage
Connecticut
$532K +$532K +215 New
CM
23
Crestline Management
Texas
$504K +$505K +204 New
DWM
24
Dakota Wealth Management
Florida
$475K +$475K +192 New
TCM
25
Tenor Capital Management
New York
$396K – – –
1
2

ICU Hedge Fund Activity: Q2 2021 in Review

33 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q2 2021, worth a combined $72.7M — up 46% from $49.6M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ICU positions and 1 closed out — a net gain of 14 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Karpus Investment Management, adding an estimated $7.77M. The largest seller was HSBC Holdings, cutting an estimated $1.9M.

  • 33 institutional investors held SeaStar Medical (ICU) as of Q2 2021, up from 19 in Q1 2021.
  • Funds reported $72.7M of SeaStar Medical stock for Q2 2021, up 46% quarter-over-quarter.
  • 15 funds opened new SeaStar Medical positions in Q2 2021 and 1 closed out, a net change of +14 holders.
  • The largest SeaStar Medical buyer in Q2 2021 was Karpus Investment Management, an estimated $7.77M added.
  • The largest SeaStar Medical seller in Q2 2021 was HSBC Holdings, an estimated $1.9M sold.

Based on aggregated 13F filings for Q2 2021.